HLA-B and hypersensitivity: According to previous studies and the CPIC guideline [22], the genotyping of the HLA-B*57:01 variant in the HLA-B gene is useful for identifying patients most likely to present hypersensitivity reactions, which consist of dyspnea, rash, fatigue, pyrexia, gastrointestinal symptoms, and cough.